What Is Recurrent Ovarian Cancer

Links shared publicly online about this topic

What Is Ovarian Cancer? What Causes Ovarian Cancer?

medicalnewstoday.com — “Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium (outer lining) of the ovary. According to thView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on August 4, 2009 at 10:11 am By:

mnt_healthnews MNT Health News Health News

What Is Ovarian Cancer? What Causes Ovarian Cancer?: Ovarian cancer is any cancerous growth that may occur in di.. http://bit.ly/hCvDW

3 years ago...

First Recurrent Gene Fusion Identified In Ovarian Cancer

medicalnewstoday.com — “Researchers studying ovarian cancer have discovered that, in a substantial fraction of ovarian tumors, a gene closely related to the estrogen receptor is broken and fused to an adjacent gene by aView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 22, 2011 at 7:05 am By:

mnt_ovariancanc MNT Ovarian Cancer Health News

First Recurrent Gene Fusion Identified In Ovarian Cancer http://mnt.to/3ZMY #ovariancancer

5 months ago...

What is Ovarian Cancer? Video

vodpod.com — “Ovarian cancer begins in one or both of the ovaries (the reproductive glands in women that produce eggs). One of the reasons many women who are diagnosed with ovarian cancer die of its complications if the symptoms are nonspecific. 10 Jul. 10. Ovarian cancer begins in one or both of the ovaries (the reproductive glands in women that produce eggs). One of the reasons many women who are diagnosed with ovarian cancer die of its complications if the symptoms are nonspecific.View full resource at vodpod.com

  • View Related
  • Share

Most Recently Shared on July 11, 2010 at 1:26 am By:

libbyshope Paul Cacciatore Patient Advocate

Ovarian cancer begins in one or both of the ovaries (the reproductive glands in women that produce eggs). One of the r… http://bit.ly/ajRIPU

2 years ago...

Early decline in cancer antigen 125 as a surrogate for progression-free survival in recurrent ovarian cancer

blog.mdlinx.com — “The findings of this study are opposite to what would be expected if these markers were good surrogates for treatment benefit.View full resource at blog.mdlinx.com

  • View Related
  • Share

Most Recently Shared on August 15, 2011 at 9:51 pm By:

MDLinx Sandeep Pulim MD Physician, Doctor, and Health Communicator

Early decline in cancer antigen 125 as a surrogate for progression-free survival in recurrent ovarian cancer http://t.co/4Kziuul

6 months ago...

Unique Genetic Marker May Improve Detection Of Recurrent Ovarian Cancer

medicalnewstoday.com — “Ovarian cancer is a major health concern for women and the identification of sensitive biomarkers for early detection and/or monitoring of disease recurrence is of high clinical relevance.View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 9, 2011 at 9:07 am By:

mnt_ovariancanc MNT Ovarian Cancer Health News

Unique Genetic Marker May Improve Detection Of Recurrent Ovarian Cancer http://t.co/7OgdD8rC #ovariancancer

2 months ago...

Can Diet and Exercise Reduce Recurrences of Ovarian Cancer? - EmpowHER.com

empowher.com — “Read about a new study that is looking to determine if a low-fat diet and increase in exercise may lower the risk of recurrence in ovarian cancer.View full resource at empowher.com

  • View Related
  • Share

Most Recently Shared on February 9, 2011 at 6:56 pm By:

Bevacizumab Added to Chemotherapy Provides Meaningful Benefit in Recurrent Ovarian Cancer

onclive.com — “Women with recurrent platinum-sensitive ovarian cancer had a 50% improvement in PFS when bevacizumab was added to chemotherapy and continued as maintenance therapy.View full resource at onclive.com

  • View Related
  • Share

Most Recently Shared on July 27, 2011 at 7:45 pm By:

ONClive Editor Oncology

Bevacizumab Added to Chemotherapy Provides Meaningful Benefit in Recurrent Ovarian Cancer http://t.co/gLOIrDB

6 months ago...

Oxaliplatin + Doxorubicin in Recurrent Ovarian Cancer Shows Promise, Tolerability - ONA

oncologynurseadvisor.com — “The combination of oxaliplatin and doxorubicin showed promising efficacy in either platinum-sensitive or platinum-resistant recurrent ovarian cancer, as reported by Ilya Pokateav, MD, from the Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, and colleagues at the American Society of Clinical Oncology’s 2011 Annual Meeting.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on June 5, 2011 at 5:23 pm By:

ONAcom OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology

Oxaliplatin + Doxorubicin in Recurrent Ovarian Cancer Shows Promise, Tolerability http://goo.gl/fb/ldXlW

8 months ago...

Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer - ONA

oncologynurseadvisor.com — “Amgen announced that AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial involving 161 patients with recurrent ovarian cancer.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on June 7, 2010 at 8:20 pm By:

Dr. Karlan Discusses AMG 386 in Recurrent Ovarian Cancer

onclive.com — “Beth Y. Karlan MD Discusses AMG 386 in Recurrent Ovarian CancerView full resource at onclive.com

  • View Related
  • Share

Most Recently Shared on May 5, 2011 at 6:51 pm By:

ONClive Editor Oncology

OncLive TV: Dr. Beth Karlan from @CedarsSinai Discusses AMG 386 in Recurrent Ovarian Cancer http://goo.gl/eO2xa

9 months ago...

Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer - MPR

empr.com — “Amgen announced that AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial involving 161 patients with recurrent ovarian cancer.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on June 7, 2010 at 8:14 pm By:

eMPR MPR Medical Publisher

MPR News: Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer: Amgen announced that AMG 386, combin... http://bit.ly/cBbIUj

2 years ago...

Bevacizumab Halves Progression Risk in Recurrent Ovarian Cancer : Internal Medicine News

internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice treView full resource at internalmedicinenews.com

  • View Related
  • Share

Most Recently Shared on June 5, 2011 at 11:58 pm By:

MiriamETucker Miriam E. Tucker Patient Expert

RT @IntMedNews: Bevacizumab Halves Progression Risk in Recurrent Ovarian #Cancer http://bit.ly/ipBNsP

8 months ago...

Detecting breast cancer recurrence

physorg.com — “Connie Krabbe understands the fear and foreboding breast cancer survivors feel when visiting their physicians for post-treatment check-ups. Two of her four sisters died of metastatic cancer related to breast cancer, enduring bone, brain and ovarian cancer before succumbing to the disease in their early ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on October 20, 2010 at 3:12 pm By:

Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer

hindawi.com — “Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian CancerView full resource at hindawi.com

  • View Related
  • Share

Most Recently Shared on August 29, 2011 at 6:40 pm By:

OvarianCancer_ Ovarian Cancer OW OW Health

Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer: Thi... http://t.co/C0fygZk

5 months ago...

Oncology Article | ovarian cancer

mdlinx.com — “Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohortView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on September 1, 2011 at 10:32 am By:

MDLinx Sandeep Pulim MD Physician, Doctor, and Health Communicator

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive su... http://t.co/VTK4Upu #oncology

5 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390